Back to Business

Novartis faces drug pipeline test with valuation premium in focus

Business July 20, 2026 at 5:12 AM

Novartis faces drug pipeline test with valuation premium in focus

Investing.com

Read at Investing.com

More Stories

Zions Q2 2026 slides: strong core results, credit quality shines

Zions Q2 2026 slides: strong core results, credit quality shines

🇺🇸 Investing.com 45m ago

Airbus CEO says H1 deliveries consistent with annual goal

Airbus CEO says H1 deliveries consistent with annual goal

🇺🇸 Investing.com 49m ago

Son of Brazil’s former President Bolsonaro secures US green card

Son of Brazil’s former President Bolsonaro secures US green card

🇺🇸 Investing.com 50m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play